Store Price
EntirelyPets
$460.99

Vanguard crLyme the first and only chimeric recombinant canine Lyme disease vaccine. VANGUARD crLyme helps provide broad-spectrum coverage against outer surface protein A (OspA), found in the tick, and contains antigens from multiple types of outer surface protein C (OspC), found in the tick and dog. Indications For vaccination of healthy dogs 8 weeks of age or older as an aid in the prevention of clinical disease and subclinical arthritis associated with Borrelia burgdorferi.

Sku Z061777

Upc

No reviews

Write a review

Your review will appear on the website after it has been approved. Thank you for your contribution.

Sign up to our Newsletter

Sign up content.